The ABCs in the Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: An Introductory Remark on Expert Perspectives

著者: Wanner, Christoph
出版年 Clin J Am Soc Nephrol (2018)

Magnesium in disease

著者: Geiger, Helmut, Wanner, Christoph
出版年 Clin Kidney J (2012)

The Obesity Paradox and the Role of Inflammation

著者: Drechsler, Christiane, Wanner, Christoph
出版年 J Am Soc Nephrol (2016)

Uromodulin in the Bloodstream: Old Wine in a New Wineskin

著者: Kraus, Daniel, Wanner, Christoph
出版年 J Am Soc Nephrol (2017)

Will the FAbry STabilization indEX make its way to everyday clinical practice?

著者: Cairns, Tereza, Wanner, Christoph
出版年 Clin Kidney J (2018)

Fifty years of ERA-EDTA Registry—a registry in transition

著者: Jager, Kitty J, Wanner, Christoph
出版年 Kidney Int Suppl (2011) (2015)

Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes—A Proposed MARE Definition

著者: Prischl, Friedrich C., Wanner, Christoph
出版年 Kidney Int Rep (2018)

Life/2020—the future of kidney disease

著者: Stenvinkel, Peter, Fouque, Denis, Wanner, Christoph
出版年 Nephrol Dial Transplant (2020)

A Janus‐headed electrolyte and ‘RALES' disease’

著者: Kraus, Daniel, Wanner, Christoph, Kraus, Bettina J.
出版年 ESC Heart Fail (2017)

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease

著者: Heerspink, Hiddo J L, Fouque, Denis, Wanner, Christoph
出版年 Nephrol Dial Transplant (2020)

Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting list

著者: Herzog, Anna Laura, Kalogirou, Charis, Wanner, Christoph, Lopau, Kai
出版年 Clin Kidney J (2019)

Understanding competing risks: a simulation point of view

著者: Allignol, Arthur, Schumacher, Martin, Wanner, Christoph, Drechsler, Christiane, Beyersmann, Jan
出版事項 2011

Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles

著者: Oder, Daniel, Vergho, Dorothee, Ertl, Georg, Wanner, Christoph, Nordbeck, Peter
出版年 BMC Med Genet (2016)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy

著者: Müntze, Jonas, Salinger, Tim, Gensler, Daniel, Wanner, Christoph, Nordbeck, Peter
出版年 Eur Heart J (2018)

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

著者: Winkler, Karl, Wanner, Christoph, Drechsler, Christiane, Lilienthal, Jürgen, März, Winfried, Krane, Vera
出版事項 2008

Antibodies to Platelet Factor 4–Heparin Complex and Outcome in Hemodialysis Patients with Diabetes

著者: Krane, Vera, Berger, Mario, Lilienthal, Jürgen, Winkler, Karl, Schambeck, Christian, Wanner, Christoph
出版事項 2010

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

著者: Winkler, Karl, Wanner, Christoph, Drechsler, Christiane, Lilienthal, Jürgen, März, Winfried, Krane, Vera
出版事項 2008

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study

著者: Locatelli, Francesco, Spasovski, Goce, Dimkovic, Nada, Wanner, Christoph, Dellanna, Frank, Pontoriero, Giuseppe
出版事項 2014

Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time

著者: Krieter, Detlef H., Kerwagen, Simon, Rüth, Marieke, Lemke, Horst-Dieter, Wanner, Christoph
出版年 Toxins (Basel) (2019)

Hot topics in Fabry disease

著者: Cairns, Tereza, Müntze, Jonas, Gernert, Judith, Spingler, Lisa, Nordbeck, Peter, Wanner, Christoph
出版年 Postgrad Med J (2018)